Furosemide-Claris 20mg/2ml Injection - AUST R 148003, intended for the Australian market (CLDA (16)A/04)

Claris Lifesciences UK Ltd are asking pharmacists and wholesalers to check packs of Furosemide-Claris 20mg/2ml Injection (Marketing Authorisation number AUST R 148003) as they have been inadvertently distributed in the UK and are intended for the Australian market.

Product information

CLDA number

CLDA (16)A/04

MDR number

MDR 11-08/16

Company name

Claris Lifesciences UK Ltd

Product description

Furosemide-Claris 20mg/2ml Injection Marketing Authorisation number AUST R 148003, intended for the Australian market.

Batch number/expiry

Batch no Expiry date
B550131 April 2018

Brief description of the problem

Claris Lifesciences UK Ltd has informed us that, due to the possible mislabelling of shipping cartons at the manufacturing site, some packs of the above product may have inadvertently been distributed in the UK. Pharmacists and wholesalers are asked to check their stock of this product and notify Claris Lifesciences UK Ltd if any Australian packs from the above batch are identified.

Company contact for all enquiries

Claris Lifesciences UK Ltd
The Granary, The Courtyard Barns
Choke Lane, Cookham Dean,
Maidenhead, Berkshire
United Kingdom
Tel: 01908 363498

Email: medinfo@peckforton.com

Published 10 August 2016